Loading stock analysis…
Evidence Synthesis
Last synthesized: 9 Jul 2026, 06:50
Evidence Synthesis
Here's a standard_shift narrative based on the provided payload: HCG accelerated its gross margin to 36.36%, up from 9.55%.
The company's marginal operating leverage accelerated to , up from 0.54%. HCG also saw a revenue growth yoy of , accelerating from -71.2%. However, the close price is decelerating to , down from 647.65 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 36.36 % | 9.55 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 9.55 % | 0.54 | ▲ |
| REVENUE_GROWTH_YOY | 11.5 % | -71.2 | ▲ |
| EPS_ACTUAL | 0.34 INR | 1.16 | ▼ |
| EPS_SURPRISE_PERCENT | -0.514 % | -0.216 | ▼ |
| PRICE_CHANGE_PERCENT | -2.03 % | — | - |
| DAILY_VOLUME | 5,67,386 shares | 1,64,763 | ▲ |
| CLOSE_PRICE | 634.5 INR | 647.65 | ▼ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 9 | ▼ |
| TARGET_PRICE_PREMIUM | 22.86 % | — | - |